Neutrophils, as “Trojan horses”, participate in the delivery of therapeutical PLGA nanoparticles into a tumor based on the chemotactic effect

References

• Alexander A, Ajazuddin J, Khan S, et al. (2013). Poly(ethylene glycol)-poly(lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications. J Control Rel 172:715–29.
   PubMed Web of Science ®Google Scholar
• Birnbaum DT, Kosmala JD, Brannon-Peppas L. (2000). Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles. J Nanoparticle Res 2:173–81.
   Web of Science ®Google Scholar
• Bryan Ronain S, Ghosn EEB, Harikrishna R, et al. (2014). Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotech 9:481–7.
   PubMed Web of Science ®Google Scholar
• Cai X, Luan Y, Jiang Y, et al. (2012). Huperzine A-phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release. Int J Pharmaceut 433:102–11.
   PubMed Web of Science ®Google Scholar
• Cao X, Hu Y, Luo S, et al. (2019). Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharmaceut Sin B 9:575–89.
   PubMed Web of Science ®Google Scholar
• Choi J, Kim HY, Ju EJ, et al. (2012). Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials 33:4195–203.
   PubMed Web of Science ®Google Scholar
• Choi JS, Cao J, Naeem M, et al. (2014). Size-controlled biodegradable nanoparticles: preparation and size-dependent cellular uptake and tumor cell growth inhibition. Colloids Surf B Biointerfaces 122:545–51.
   PubMed Web of Science ®Google Scholar
• Choi MR, Stanton-Maxey KJ, Stanley JK, et al. (2007). A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 7:3759–65.
   PubMed Web of Science ®Google Scholar
• Chu D, Jin G, Wang Z. (2015). Neutrophil-mediated delivery of therapeutic nanoparticles across blood vessel barrier for treatment of inflammation and infection. Acs Nano 9:11800–11.
   PubMed Web of Science ®Google Scholar
• Chu D, Dong X, Shi X, et al. (2018). Neutrophil-based drug delivery systems. Adv Mater 30:1706245.
   PubMed Web of Science ®Google Scholar
• Chu D, Qi Z, Jian Y, et al. (2016). Nanoparticle targeting of neutrophils for improved cancer immunotherapy. Adv Healthcare Mater 5:1088–93.
   Web of Science ®Google Scholar
• Coffelt SB, Wellenstein MD, Visser KED. (2016). Neutrophils in cancer: neutral no more. Nat Rev Cancer 16:431–46.
   PubMed Web of Science ®Google Scholar
• Danhier F. (2016). To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Rel 244:108–21.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J Control Rel 161:505–22.
   PubMed Web of Science ®Google Scholar
• Dong X, Chu D, Wang Z. (2017). Leukocyte-mediated delivery of nanotherapeutics in inflammatory and tumor sites. Theranostics 7:751–63.
   PubMed Web of Science ®Google Scholar
• Eyileten C, Majchrzak K, Pilch Z, et al. (2016). Immune cells in cancer therapy and drug delivery. Mediators Inflamm 2016:1–13.
   Web of Science ®Google Scholar
• Hu CMJ, Zhang L, Aryal S, et al. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci 108:10980–5.
   PubMed Web of Science ®Google Scholar
• Huang Y, Gao X, Chen J. (2018). Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy. Acta Pharmaceut Sin B 8:4–13.
   PubMed Web of Science ®Google Scholar
• Jiang W, Roemeling CAV, Chen Y, et al. (2017). Designing nanomedicine for immuno-oncology. Nat Biomed Eng 1:29–41.
   Web of Science ®Google Scholar
• Jijun F, Dan W, Dong M, et al. (2015). Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer. J Control Rel 204:11–9.
   PubMed Web of Science ®Google Scholar
• Kang T, Zhu Q, Wei D, et al. (2017). Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. Acs Nano 11:1397.
   PubMed Web of Science ®Google Scholar
• Kruger P, Saffarzadeh M, Weber ANR, et al. (2015). Neutrophils: between host defence, immune modulation, and tissue injury. PLoS Pathog 11:e1004651.
   PubMed Web of Science ®Google Scholar
• Luo M, Peng H, Deng Z, et al. (2015). A simple equation for the description of solute release II. Fickian and anomalous release from swellable devices. Int J Food Eng 5:37–42.
   Google Scholar
• Ma H, He C, Cheng Y, et al. (2014). PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment. Biomaterials 35:8723–34.
   PubMed Web of Science ®Google Scholar
• Maeda H. (2013). The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci 104:779–89.
   PubMed Web of Science ®Google Scholar
• Michor F, Liphardt J, Ferrari M, Widom J. (2011). What does physics have to do with cancer? Nat Rev Cancer 11:657–70.
   PubMed Web of Science ®Google Scholar
• Nicolás-Ávila JÁ, Adrover JM, Hidalgo A. (2017). Neutrophils in homeostasis, immunity, and cancer. Immunity 46:15–28.
   PubMed Web of Science ®Google Scholar
• Parodi A, Quattrocchi N, Al VDV, et al. (2013). Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotech 8:61–8.
   PubMed Web of Science ®Google Scholar
• Pratoomsoot C, Tanioka H, Hori K, et al. (2008). A thermoreversible hydrogel as a biosynthetic bandage for corneal wound repair. Biomaterials 29:272–81.
   PubMed Web of Science ®Google Scholar
• Song G, Tarrant TK, White TF, et al. (2015). Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer. Nanomed Nanotechnol Biol Med 11:1797–807.
   PubMed Web of Science ®Google Scholar
• Tan S, Wu T, Zhang D, Zhang Z. (2015). Cell or cell membrane-based drug delivery systems. Theranostics 5:863–81.
   PubMed Web of Science ®Google Scholar
• Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5.
   PubMed Web of Science ®Google Scholar
• Vij N, Min T, Bodas M, et al. (2016). Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases. Nanomed Nanotechnol Biol Med 12:2415–27.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao Y, Wang H, et al. (2014). Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer. J Control Rel 192:47–56.
   PubMed Web of Science ®Google Scholar
• Xue J, Zhao Z, Zhang L, et al. (2017). Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nature Nanotech 12:692–700.
   PubMed Web of Science ®Google Scholar